A method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signalling

Details for Australian Patent Application No. 2004221792 (hide)

International Classifications

Event Publications

6 October 2005 PCT application entered the National Phase

PCT publication WO2004/083453 Priority application(s): WO2004/083453

9 April 2009 Application Accepted

Published as AU-B-2004221792

4 June 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 12 May 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

1 October 2009 Standard Patent Sealed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.